Héma-Québec studies

SEROPREVALENCE STUDIES

Studies conducted by Héma-Québec in collaboration with the Institut national de santé publique (INSPQ), and in partnership with the COVID-19 Immunity Task Force (CITF), aim to measure the progression of immunity in the population.

CLINICAL STUDY ON CONVALESCENT PLASMA

Héma-Québec was involved in a national clinical trial project, with the objective of developing a passive immunization program for treating people with COVID-19.

PLASCOV PROJECT

The study aims to measure the impact of vaccination, or infection, on the immune response.